Key Insights

Highlights

Treatment Research

4 treatments under study, led by Pscbmnc

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Recruiting1
Unknown1

Clinical Trials (2)

Showing 2 of 2 trials
NCT03855202Phase 1UnknownPrimary

The Treatment of Bronchopulmonary Dysplasia by Instillation PS and Mononuclaer Cells in Preterms

NCT03019692RecruitingPrimary

Longterm Outcome of Children With Neonatal Intra-Ventricular or Intra-Cranial Hemorrhage

Showing all 2 trials

Research Network

Common Treatments

  • Pscbmnc1
  • Placeo1
  • Ps1
  • Cbmnc1

Active Sponsors

  • Laniado Hospital1
  • yangjie1

Top Investigators

Related Conditions

  • Ventilator Support1

Activity Timeline